Fortress Biotech (FBIO) Profit After Tax (QoQ) (2010 - 2025)
Powered by 
Analysis
Fortress Biotech (FBIO) Profit After Tax (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -161.14% |
| Sep 30, 2025 | -43.00% |
| Jun 30, 2025 | 162.72% |
| Mar 31, 2025 | 6.17% |
| Dec 31, 2024 | 1.42% |
| Sep 30, 2024 | 7.39% |
| Jun 30, 2024 | 26.14% |
| Mar 31, 2024 | -34.64% |
| Dec 31, 2023 | -170.27% |
| Sep 30, 2023 | 81.92% |
| Jun 30, 2023 | -7.54% |
| Mar 31, 2023 | 4.00% |
| Dec 31, 2022 | -8.26% |
| Sep 30, 2022 | -147.94% |
| Jun 30, 2022 | -20.22% |
| Mar 31, 2022 | 74.02% |
| Dec 31, 2021 | -49.38% |
| Sep 30, 2021 | -88.02% |
| Jun 30, 2021 | 6.43% |
| Mar 31, 2021 | -27.21% |